HiTT develops projects for top pharma companies, start-ups, government agencies and consultancy firms in the health industry.
Fundations and public institutions
Oriol Sola Morales has collaborated in the creation of an article about reimbursement decisions on new oncology drugs. You can access to the entire article in this link.
Health Innovation Technology Transfer (HITT) is working on the development of an European project in Big Data tools. This project tries to understand the needs of the professionals that use Big Data tools in its analytical procedures.
Today we learn that Amgen is lowering the acquisition cost of Repatha by 60% in the US.